Orbactiv 01
Chemical structure of oritavancin, the active ingredient in Orbactiv 400 mg intravenous injection, powder, lyophilized for solution.*
Orbactiv Injection, Powder, Lyophilized, For Solution
Product Images NDC 70842-140
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orbactiv (NDC 70842-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Melinta Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Orbactiv 02
Packaging label for Orbactiv (oritavancin) for injection, 400 mg per vial, powder for intravenous infusion only. The label indicates a single-dose vial with unused portions to be discarded. Marketed by Melinta Therapeutics, LLC. Contains instructions for reconstitution and dilution, and a note that the package contains three 400 mg single-dose vials.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
